Form D · Other Technology
BACCH Laboratories, Inc.
Gainesvile, FL · CIK 0001471363
Offering snapshot reported Jul 30, 2025 · SEC filing
- Reported sold
- $1.81M Offering amount: $3.56M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2025 | Initial | $1,810,150 | No comparison | 27 | SEC filing |
| Jul 30, 2025 | Initial | $810,000 | No comparison | 14 | SEC filing |
| Jun 23, 2025 | Amendment | $2,916,000 | $2,626,000vs Nov 22, 2019 | 48 | SEC filing |
| Feb 9, 2021 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Nov 22, 2019 | Initial | $290,000 | No comparison | 11 | SEC filing |
| Jan 22, 2019 | Initial | $2,602,200 | No comparison | 41 | SEC filing |
| Jun 4, 2018 | Amendment | $1,500,000 | $1,458,946vs May 1, 2018 | 29 | SEC filing |
| May 1, 2018 | Initial | $41,054 | No comparison | 7 | SEC filing |
| Sep 20, 2017 | Initial | $246,749 | No comparison | 21 | SEC filing |
| Jan 13, 2017 | Initial | $1,223,958 | No comparison | 14 | SEC filing |
| Oct 12, 2011 | Initial | $743,958 | No comparison | 12 | SEC filing |
| Feb 11, 2011 | Amendment | $1,568,426 | $140,000vs Oct 29, 2010 | 21 | SEC filing |
| Oct 29, 2010 | Amendment | $1,428,426 | $360,000vs Aug 18, 2010 | 16 | SEC filing |
| Aug 18, 2010 | Amendment | $1,068,426 | $268,552vs Mar 15, 2010 | 13 | SEC filing |
| Mar 15, 2010 | Initial | $799,874 | No comparison | 10 | SEC filing |
| Mar 5, 2010 | Amendment | $427,295 | $200,000vs Sep 14, 2009 | 7 | SEC filing |
| Sep 14, 2009 | Initial | $227,295 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $9K
- Finders' fees
- $0
- Form D file number
- 021-553246
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| n/a | None | Four Points Capital Partners LLC · CRD 43149 |
Source: Form D, filed Jul 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Allen | Director |
| Eric Buffkin | Director |
| Dan Eric Buffkin | Director |
| Samuel Caldwell | Director |
| Edgar Choueiri | Director, Executive |
| Joseph Cufari | Director |
| Garrett Gleim | Director |
| Benjamin Andrew Hoover | Director |
| James Mentz | Director, Executive |
| Robert Mentz | Executive |
| Peter D. Phillips | Director |
| Alice Sammon | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
747 Sw 2 Nd Avenue, Imb#11
Gainesvile, FL, 32601
Gainesvile, FL, 32601